Nolet Chris
Insider CIK 1782814 · PTE Director · RVNC Director · VIE Director · JSPR Director · AVBP Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVBP ArriVent BioPharma, Inc. | A Award deriv | 2026-06-18 | 2026-06-22 | 13,562 | — | $0 | 13,562 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2025-07-03 | 2025-07-03 | 7,500 | — | $0 | 7,500 | SEC↗ |
| AVBP ArriVent BioPharma, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 15,502 | — | $0 | 15,502 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | D To issuer | 2025-02-06 | 2025-02-06 | 15,000 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | U Tender | 2025-02-04 | 2025-02-06 | 28,606 | $3.65 | $104.4K | 15,000 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 7,500 | — | $0 | 7,500 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2024-05-01 | 2024-05-03 | 23,458 | — | $0 | 23,458 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2024-05-01 | 2024-05-03 | 15,000 | — | $0 | 43,606 | SEC↗ |
| AVBP ArriVent Biopharma, Inc. | A Award deriv | 2024-01-25 | 2024-01-29 | 17,884 | — | $0 | 17,884 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-08 | 47,000 | — | $0 | 47,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2023-05-03 | 2023-05-05 | 5,915 | — | $0 | 5,915 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2023-05-03 | 2023-05-05 | 3,534 | — | $0 | 28,606 | SEC↗ |
| PTE POLARITYTE, INC. | M Exercise deriv | 2023-01-12 | 2023-01-17 | 3,078 | — | $0 | 6,157 | SEC↗ |
| PTE POLARITYTE, INC. | M Exercise | 2023-01-12 | 2023-01-17 | 36,497 | — | $0 | 14,403 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award | 2022-10-12 | 2022-10-13 | 32,500 | — | $0 | 32,500 | SEC↗ |
| PTE POLARITYTE, INC. | A Award | 2022-10-01 | 2022-10-04 | 50,900 | — | $0 | 50,900 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2022-05-04 | 2022-05-06 | 11,343 | — | $0 | 11,343 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2022-05-04 | 2022-05-13 | 10,756 | — | $0 | 10,756 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2022-05-04 | 2022-05-06 | 6,059 | — | $0 | 25,072 | SEC↗ |
| JSPR Jasper Therapeutics, Inc. | A Award deriv | 2022-03-21 | 2022-03-23 | 78,045 | — | $0 | 78,045 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2021-05-05 | 2021-05-07 | 7,551 | — | $0 | 7,551 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2021-05-05 | 2021-05-07 | 4,013 | — | $0 | 19,013 | SEC↗ |
| VIE Viela Bio, Inc. | D To issuer deriv | 2021-03-15 | 2021-03-15 | 7,358 | — | $0 | 0 | SEC↗ |
| VIE Viela Bio, Inc. | D To issuer deriv | 2021-03-15 | 2021-03-15 | 26,210 | — | $0 | 0 | SEC↗ |
| PTE POLARITYTE, INC. | A Award deriv | 2021-01-01 | 2021-01-05 | 166,443 | $0.48 | $79.9K | 166,443 | SEC↗ |
| VIE Viela Bio, Inc. | A Award deriv | 2020-06-19 | 2020-06-23 | 7,358 | — | $0 | 7,358 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2020-05-14 | 2020-05-15 | 12,000 | — | $0 | 12,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2020-05-14 | 2020-05-15 | 6,000 | — | $0 | 15,000 | SEC↗ |
| PTE POLARITYTE, INC. | A Award deriv | 2020-04-06 | 2020-04-07 | 230,894 | — | $0 | 230,894 | SEC↗ |
| VIE Viela Bio, Inc. | A Award deriv | 2019-10-02 | 2019-10-02 | 26,210 | — | $0 | 26,210 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2019-07-16 | 2019-07-18 | 18,000 | — | $0 | 18,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award | 2019-07-16 | 2019-07-18 | 9,000 | — | $0 | 9,000 | SEC↗ |